drugset / Trial / NCT00601770
Virological Response Study of the HCV Vaccine IC41
NaSingle-groupOpen-labelTreatment
Summary
The objective is to investigate the virological (HCV-RNA) responses following biweekly immunization with IC41. Treatment phase 14 weeks, total study duration including follow-up period 38 weeks.
Timeline
- Start
- 2006-02
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IC41 | Vaccine | 0.125 ml | Other |